Product NDC: | 55045-3259 |
Proprietary Name: | TERCONAZOLE |
Non Proprietary Name: | terconazole |
Active Ingredient(s): | 8 mg/g & nbsp; terconazole |
Administration Route(s): | VAGINAL |
Dosage Form(s): | CREAM |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55045-3259 |
Labeler Name: | Dispensing Solutions, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA019964 |
Marketing Category: | NDA |
Start Marketing Date: | 20040401 |
Package NDC: | 55045-3259-3 |
Package Description: | 20 g in 1 TUBE, WITH APPLICATOR (55045-3259-3) |
NDC Code | 55045-3259-3 |
Proprietary Name | TERCONAZOLE |
Package Description | 20 g in 1 TUBE, WITH APPLICATOR (55045-3259-3) |
Product NDC | 55045-3259 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | terconazole |
Dosage Form Name | CREAM |
Route Name | VAGINAL |
Start Marketing Date | 20040401 |
Marketing Category Name | NDA |
Labeler Name | Dispensing Solutions, Inc. |
Substance Name | TERCONAZOLE |
Strength Number | 8 |
Strength Unit | mg/g |
Pharmaceutical Classes | Azole Antifungal [EPC],Azoles [Chemical/Ingredient] |